EQRx, Inc.

EQRx, Inc. (Nasdaq: EQRX) is a biopharmaceutical company focused on developing and commercializing medicines at dramatically lower prices, positioning itself as a disruptor to conventional pharmaceutical pricing models. The company filed its S-1 registration statement on December 21, 2021, as part of its path to the public markets via a SPAC business combination. EQRx operates in the healthcare and life sciences sector, with a pipeline targeting oncology and immunology indications. The December 2021 filing marked a key milestone in its de-SPAC process, bringing heightened scrutiny to its novel commercial model at a time of intense investor interest in healthcare SPACs. Visit SpacDesk and sign up for full data, filings, and analytics on EQRx and hundreds of other SPAC transactions.